The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; none of the 35 sources its claims cite is checked for support yet.
Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth
Open accessAbstract
The role of Golgi/endosome-localized clathrin adapters in the maintenance of steady-state cell surface epidermal growth factor receptor (EGFR) is not well known. Here, we show that EGFR associates preferentially with both AP-1 and GGA2 in vitro. AP-1 depletion caused a reduction in the EGFR protein by promoting its lysosomal degradation. Triple immunofluorescence microscopy and proximity ligation assays demonstrated that the interaction of EGFR with AP-1 or GGA2 occurred more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes. Biochemical recycling assay revealed that the depletion of AP-1 or GGA2 significantly suppressed EGFR recycling to the plasma membrane regardless of the EGF stimulation. Depletion of AP-1 or GGA2 also reduced cell contents of other tyrosine kinases, MET and ErbB4, and therefore, suppressed the growth of H1975 cancer cells in culture and xenograft model. Moreover, AP-1 was expressed in endosomes at higher levels in some cancer tissues. Collectively, these results suggest that AP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and, consequently, cancer cell growth.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
AP-1 and GGA2 interact with EGFR preferentially in Rab11-positive recycling endosomes and support EGFR recycling to the plasma membrane, thereby maintaining cell surface EGFR and cell growth. Depletion of AP-1 or GGA2 reduces EGFR and other RTKs, suppresses cancer cell growth in culture and xenografts, and AP-1 distribution is altered in some human cancers.
Key findings
- AP-1 depletion reduced EGFR protein by accelerating its lysosomal degradation; pulse-chase showed significantly increased EGFR turnover (P < 0.01–0.05), while EGFR mRNA and newly translated protein were unchanged.
- AP-1 and GGA2 interacted with EGFR preferentially in Rab11-positive recycling endosomes: about 49–52% of AP-1/GGA2–EGFR PLA signal overlapped with Rab11-positive structures versus 13–15% with Rab5-positive ones.
- Depletion of AP-1 or GGA2 significantly reduced cell surface EGFR (P < 0.001) and EGFR recycling to the plasma membrane (P < 0.05 or 0.01) regardless of EGF stimulation; MET and ErbB4 were also decreased.
- AP-1 depletion suppressed growth of ARPE-19 and H1975 cells in culture (P < 0.05–0.001) and H1975 xenograft tumor growth (P < 0.001); AP-1-positive granular structures were more evident in tumor versus non-tumor regions in 68–84% of cancer tissues, with significantly higher mean intensity in NSCLC but not HCC or CRC.
Methods
- Immunoprecipitation coupled with mass spectrometry and western blotting in ARPE-19 and H1975 cells identified EGFR-associated clathrin adapters; siRNA/shRNA knockdown of AP-1 subunits or GGA2 was used for functional assays.
- EGFR trafficking was analyzed by pulse-chase with [35S]-methionine/cysteine, surface biotinylation, internalization/recycling assays, immunofluorescence microscopy, and proximity ligation assays.
- Cell growth was measured in culture and in H1975 xenografts; human tissue arrays of HCC, NSCLC, and CRC were immunostained, with statistical comparisons by Student’s t-test or Mann–Whitney U-test.
Limitations
- The paper states that whether AP-1/GGA2 interact with liganded and/or non-liganded EGFR remains a future issue, and that predicted growth effects in cancer tissues may not be mediated solely by EGFR upregulation.
- The paper also states that clathrin adapter-associated molecules such as Arf1 and accessory proteins need to be investigated using human samples.
- Evident from the text: mechanistic conclusions rely mainly on ARPE-19 and H1975 cell lines plus an H1975 xenograft, and human tissue analysis is limited to expression/distribution in arrays without direct functional perturbation; AP-1 mean intensity was not significantly higher in HCC or CRC.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 35 cited sources checked · 0 supported · 0 flagged
- Findingown data
Depletion of AP-1 or GGA2 increases CIMPR in both total and cell surface fractions.
“One of well-known cargoes of AP-1/GGA2, cation independent (CI) MPR was rather increased by the depletion of AP-1/GGA2 in both total and cell surface fraction, which is consistent with previous data [25–27].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [25] Ghosh P, Griffith J, Geuze HJ, Kornfeld S. Mammalian GGAs act together to sort mannose 6-phosphate receptors. J Cell Biol. 2003;163:755–66. source
- cites [26] Meyer C, Eskelinen EL, Guruprasad MR, von Figura K, Schu P. Mu 1A deficiency induces a profound increase in MPR300/IGF-II receptor internalization rate. J Cell Sci. 2001;114:4469–76. source
- cites [27] Navarro Negredo P, Edgar JR, Wrobel AG, Zaccai NR, Antrobus R, Owen DJ, et al. Contribution of the clathrin adaptor AP-1 subunit micro1 to acidic cluster protein sorting. J Cell Biol. 2017;216:2927–43. source
- Findingown data
Depletion of AP-1 or GGA2 significantly suppresses EGFR recycling to the plasma membrane regardless of EGF stimulation.
“Biochemical recycling assay revealed that the depletion of AP-1 or GGA2 significantly suppressed EGFR recycling to the plasma membrane regardless of the EGF stimulation.”
- Also stated in: § AP-1 and GGA2 support recycling of EGFR back to the PM · hedged
“These results together with the PLA data under EGF stimulation as described above (Supplementary Fig. S4C) suggest that AP-1 and GGA2 support the recycling of EGFR regardless of the EGF stimulation.”
Quote in the paperSubstantial claim - Also stated in: § AP-1 and GGA2 support recycling of EGFR back to the PM · hedged
- Findingown data
EGFR associates preferentially with both AP-1 and GGA2 in vitro.
“Here, we show that EGFR associates preferentially with both AP-1 and GGA2 in vitro.”
- Also stated in: § AP-1-depletion causes a reduction of EGFR protein · boosted
“These assays revealed a strong EGFR interaction with AP-1 and GGA2 and a weak interaction with AP-4 and AP-5, and little interaction with AP-3, GGA1, or GGA3 in both cell-types (Fig. 1B).”
Quote in the paperSubstantial claim - Also stated in: § AP-1-depletion causes a reduction of EGFR protein · boosted
- Findingown data
The interaction of EGFR with AP-1 or GGA2 occurs more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes.
“Triple immunofluorescence microscopy and proximity ligation assays demonstrated that the interaction of EGFR with AP-1 or GGA2 occurred more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes.”
- Also stated in: § AP-1 and GGA2 interact with EGFR at the recycling endosomes · hedged
“Quantification revealed that about 49–52% of the signal for AP-1/GGA2–EGFR interaction overlapped with Rab11-positive structures, while it was 13–15% with Rab5-positive ones (Fig. 4D), indicating that the interactions between AP-1/GGA2 and EGFR occur preferentially in the recycling endosomes.”
Quote in the paperSubstantial claim - Also stated in: § AP-1 and GGA2 interact with EGFR at the recycling endosomes · hedged
- Findingown data
Depletion of AP-1 or GGA2 reduces MET in H1975 cells.
“In H1975 cells that have minimal expression of Erb-B4 (Supplementary Fig. S6B), MET were significantly decreased by AP-1/GGA2 depletion (P < 0.01 or 0.001; Fig. 7B and Supplementary Fig. S6A).”
Quote in the paperNot a substantial claim
- Findingown data
Depletion of AP-1 or GGA2 suppresses growth of H1975 cancer cells in culture.
“and therefore, suppressed the growth of H1975 cancer cells in culture and xenograft model.”
Quote in the paperSubstantial claim - Findingown data
Depletion of AP-1 or GGA2 reduces cell surface and total EGFR protein in ARPE-19 and H1975 cells.
“As shown in Fig. 3, EGFR in the cell surface was significantly decreased (P < 0.001) by depletion of either AP-1 or GGA2 in both ARPE-19 and H1975 cells, which is comparable with the decrease in the total protein.”
- Also stated in: § Depletion of AP-1 or GGA2 downregulates cell surface expression of EGFR · hedged
“Together, this assay indicates that the depletion of AP-1 or GGA2 reduces the cell surface amounts as well as the total amounts of EGFR protein.”
Quote in the paperSubstantial claim - Also stated in: § Depletion of AP-1 or GGA2 downregulates cell surface expression of EGFR · hedged
- Findingown data
Depletion of AP-1 or GGA2 reduces cellular contents of MET and ErbB4 in ARPE-19 cells.
“Depletion of AP-1 or GGA2 also reduced cell contents of other tyrosine kinases, MET and ErbB4”
- Also stated in: § Depletion of AP-1 or GGA2 causes downregulation of other receptor tyrosine kinase (RTK) · plain
“We found that Erb-B4 and MET were also decreased significantly (P < 0.05 or 0.001) by depletion of either AP-1 or GGA2 in ARPE-19 cells (Fig. 7A, and Supplementary Fig. S6A).”
Quote in the paperNot a substantial claim - Also stated in: § Depletion of AP-1 or GGA2 causes downregulation of other receptor tyrosine kinase (RTK) · plain
- Findingown data
AP-1 depletion causes a reduction in EGFR protein in ARPE-19 cells.
“AP-1 depletion caused a reduction in the EGFR protein by promoting its lysosomal degradation.”
- Also stated in: § AP-1-depletion causes a reduction of EGFR protein · hedged
“These results indicate that the depletion of AP-1 causes a reduction of EGFR protein in ARPE-19 cells.”
- Also stated in: § AP-1-depletion causes a reduction of EGFR protein · plain
“When ARPE-19 cells were treated with siRNAs against γ1 (AP-1)-, δ (AP-3)-, ε (AP-4)-, and ζ (AP-5)-adaptin, γ1- and ζ-adaptin depletions led to marked decrease of EGFR (Fig. 1C).”
Quote in the paperSubstantial claim - Also stated in: § AP-1-depletion causes a reduction of EGFR protein · hedged
- Findingown data
Depletion of AP-1 or GGA2 suppresses growth of H1975 cancer cell xenografts.
“and therefore, suppressed the growth of H1975 cancer cells in culture and xenograft model.”
Quote in the paperSubstantial claim - Findingown data
Depletion of AP-1 or GGA2 causes downregulation of other RTK proteins.
“Depletion of AP-1 or GGA2 causes downregulation of other RTK proteins.”
Quote in the paperSubstantial claim - Findingown data
AP-1 and AP-5, as well as GGA2, support the steady-state cell surface expression of EGFR.
“We found that AP-1 and AP-5, as well as GGA2 support the steady-state cell surface expression of EGFR.”
Quote in the paperSubstantial claim - Findingown data
AP-1 was changed in its cellular distribution in many cases of HCC, NSCLC, and CRC.
“We found by immunohistological analysis that AP-1 was changed in its cellular distribution in many cases of HCC, NSCLC, and CRC, and also upregulated in NSCLC.”
Quote in the paperNot a substantial claim - Findingown data
Depletion of γ1-adaptin significantly lowers growth rates of ARPE-19 and H1975 cells in culture.
“In cell culture conditions, growth rates of ARPE-19 or H1975 cells depleted of γ1-adaptin were significantly lower than those of control cells (P < 0.05–0.001; Fig. 8A and Supplementary Fig. S7B).”
Quote in the paperSubstantial claim - Findingown data
AP-1 is primarily localized to EEA1-positive endosomes in HCC, NSCLC, and CRC.
“Moreover, AP-1 is primarily localized to EEA1-positive endosomes in HCC, NSCLC, and CRC, which is in line with the recycling endosome-localized AP-1 observed in cultured cells.”
Quote in the paperNot a substantial claim - Findingown data
AP-1 was upregulated in NSCLC.
“We found by immunohistological analysis that AP-1 was changed in its cellular distribution in many cases of HCC, NSCLC, and CRC, and also upregulated in NSCLC.”
Quote in the paperNot a substantial claim - Findingnone given
AP-1 and GGA2 support cell surface expression of other tyrosine kinases, MET and ErbB4.
“In addition, AP-1 and GGA2 also support cell surface expression of other tyrosine kinases, MET and ErbB4.”
- Also stated in: § Discussion · hedged
“The present study also suggests AP-1/GGA2 can support the expression of other RTKs, MET and ErbB4, which might have a significant impact on cancer growth in HCC, since MET is known to be overexpressed in this type of tumor [42].”
Quote in the paperNot a substantial claim - Also stated in: § Discussion · hedged
- Findingown data
GGA3 hardly associated with EGFR at steady-state in this study.
“since it hardly associated with EGFR at steady-state in this study (Fig. 1A).”
Quote in the paperSubstantial claim - Findingown data
AP-1 and GGA2 support EGFR recycling back to the plasma membrane regardless of EGF stimulation.
“Strikingly, both AP-1 and GGA2 interact with EGFR at Rab11-positive recycling endosomes, and support the receptor recycling back to the PM regardless of the EGF stimulation.”
- Also stated in: § Discussion · boosted
“We confirmed these associations both in vitro and in vivo, and further found that these associations specifically occur in Rab11a-positive recycling endosomes, and support the EGFR recycling.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · boosted
- Findingown data
AP-1 depletion significantly suppressed tumor growth rates in H1975 xenografts.
“In xenoplantation experiments using H1975 cells, AP-1-depletion significantly suppressed growth rates of tumors (P < 0.001; Fig. 8B and Supplementary Fig. S7C).”
Quote in the paperSubstantial claim - Findingown data
AP-1 and GGA2 interact with EGFR at Rab11-positive recycling endosomes.
“Strikingly, both AP-1 and GGA2 interact with EGFR at Rab11-positive recycling endosomes, and support the receptor recycling back to the PM regardless of the EGF stimulation.”
- Also stated in: § Discussion · boosted
“We confirmed these associations both in vitro and in vivo, and further found that these associations specifically occur in Rab11a-positive recycling endosomes, and support the EGFR recycling.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · boosted
- Findingown data
In tissue arrays, cytoplasmic granular AP-1-positive structures were more evident in tumor regions compared to non-tumor regions in 68-84% of cancer tissues (HCC, NSCLC, CRC).
“Cytoplasmic granular structures positive for AP-1 were more evident in tumor regions compared to non-tumor regions in 68–84% of cancer tissues (Fig. 8C).”
Quote in the paperNot a substantial claim - Findingown data
In AP-1-depleted ARPE-19 cells, phosphorylation of MAPK, a downstream signaling of EGFR, was significantly reduced.
“Phosphorylation of MAPK, a downstream signaling of EGFR, was significantly reduced in AP-1-depleted ARPE-19 cells (Supplementary Fig. S7A).”
Quote in the paperSubstantial claim - Findingcitation
Depletion of AP-1 suppressed cell growth in ARPE-19 and H1975 cells.
“Accordingly, cell growth was suppressed by the depletion of AP-1 in a non-cancer cell line, ARPE-19, and a NSCLC-derived cancer cell line, H1975, which harbors activating EGFR mutations [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2005;2:e73. source
- Findingown data
Depletion of either AP-1 or GGA2 does not affect expression levels of the other.
“Depletion of either AP-1 or GGA2 did not affect expression levels of the other (Fig. 6A), as reported previously [32, 33], nor did simultaneous depletion of both adapters enhance the reduction of EGFR.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [32] Uemura T, Sawada N, Sakaba T, Kametaka S, Yamamoto M, Waguri S. Intracellular localization of GGA accessory protein p56 in cell lines and central nervous system neurons. Biomed Res. 2018;39:179–87. source
- cites [33] Mardones GA, Burgos PV, Brooks DA, Parkinson-Lawrence E, Mattera R, Bonifacino JS. The trans-Golgi network accessory protein p56 promotes long-range movement of GGA/clathrin-containing transport carriers and lysosomal enzyme sorting. Mol Biol Cell. 2007;18:3486–501. source
- Findingown data
Depletion of either AP-1 or GGA2 affected the distribution of GGA2 or AP-1, respectively.
“The possible implication of AP-1-GGA2 interaction in the EGFR trafficking is partly supported by in vivo data in the present study showing that the depletion of either AP-1 or GGA2 affected the distribution of GGA2 or AP-1, respectively (Fig. 6).”
Quote in the paperSubstantial claim - Interpretationown data
AP-1 depletion promotes lysosomal degradation of EGFR.
“AP-1 depletion caused a reduction in the EGFR protein by promoting its lysosomal degradation.”
- Also stated in: § AP-1-depletion accelerates lysosomal degradation of EGFR protein · hedged
“Together with the increased turnover rate of EGFR by AP-1 knockdown (Fig. 2A), it is suggested that AP-1 depletion does not cause a drastic disturbance in the early endocytic pathway of EGFR, but enhances its transport from the endocytic pathway into lysosomes for degradation.”
Quote in the paperSubstantial claim - Also stated in: § AP-1-depletion accelerates lysosomal degradation of EGFR protein · hedged
- Interpretationcitation
GGA2 may also recognize EGFR indirectly through AP-1.
“Although GGA2 associates with the juxtamembrane domain of EGFR [15], it may also recognize EGFR indirectly through AP-1, because the hinge domain of GGA2 can directly bind the ear domain of AP-1 [37].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
- cites [37] Doray B, Ghosh P, Griffith J, Geuze HJ, Kornfeld S. Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science. 2002;297:1700–3. source
- Interpretationreasoning
AP-1/GGA2 targeting could arrest multiple cancer-related signaling pathways that originate from different RTKs.
“Nevertheless, it should be emphasized that potential AP-1/GGA2 targeting as an anti-cancer strategy is not dependent on activation mutations but on the intracellular recycling of EGFR, and that AP-1/GGA2 targeting could arrest multiple cancer-related signaling pathways that originate from different RTKs.”
Quote in the paperSubstantial claim - Interpretationcitation
Both AP-1 and GGA2 have a fundamental influence on cell growth by sustaining the expression of EGFR.
“Together with recent findings that the depletion of GGA2 suppresses cell proliferation in ARPE-19 [15], and two NSCLC-derived cancer cell lines, PC9 and H1975 [16], it is most likely that both AP-1 and GGA2 have a fundamental influence on cell growth by sustaining the expression of EGFR.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
- cites [16] O’Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg AL, Martinez VD, et al. Integrative genomic analyses identifies GGA2 as a cooperative driver of EGFR-mediated lung tumorigenesis. J Thorac Oncol. 2019;14:656–71. source
- Interpretationown data
The recruitment of AP-1 to endosomes may be more relevant than that to the TGN in these cancers.
“These observations suggest that the recruitment of AP-1 to endosomes may be more relevant than that to the TGN in these cancers.”
Quote in the paperSubstantial claim - Interpretationreasoning
Growth suppression by AP-1 depletion in H1975 cells both in vitro and in vivo is mediated by EGFR depletion.
“Moreover, since the growth of NSCLC-derived H1975 cells used in this study is known to depend on the EGFR, growth suppression by AP-1 depletion both in vitro and in vivo (Fig. 8A, B) would provide strong evidence that the effect was mediated by the EGFR depletion.”
Quote in the paperSubstantial claim- Rests on an assumption: H1975 cell growth depends on EGFR.
- Interpretationreasoning
These results suggest the involvement of AP-1 in EGFR-dependent cell growth.
“H1975 cells harbor activating EGFR mutations [17], and as such, these results suggest the involvement of AP-1 in EGFR-dependent cell growth.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2005;2:e73. source
- Premisecitation
GGA2 protein is upregulated in HCC and CRC.
“and GGA2 protein has been reported to be upregulated in HCC and CRC [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
- Study design and conductown data
The internalization rate of EGFR is not significantly affected by depletion of AP-1 or GGA2.
“We first confirmed that the internalization rate was not significantly affected by the depletion of AP-1 or GGA2 (Fig. 5B).”
Quote in the paperSubstantial claim - Interpretationown data
Alterations in intracellular distribution rather than higher expression levels of AP-1 are characteristic for tumor cells.
“suggesting alterations in intracellular distribution rather than higher expression levels of AP-1 are characteristic for tumor cells.”
Quote in the paperSubstantial claim - Interpretationown data
Accumulating evidence including our data suggests the importance of AP-1/GGA2 in cancer growth.
“Therefore, accumulating evidence including our data suggests the importance of AP-1/GGA2 in cancer growth.”
Quote in the paperSubstantial claim - Study design and conductown data
The reduction of EGFR by γ1-adaptin depletion is not due to off-target effects.
“Importantly, depletion of other subunits, µ1 or β1-adaptin also reduced EGFR (Supplementary Fig. S1D), and reexpression of γ1-adaptin slightly restored EGFR in Western blot analysis (Fig. 1E) and immunofluorescence microscopy (Supplementary Fig. S1E), excluding a possibility of off-target effects.”
Quote in the paperSubstantial claim - Interpretationown data
The present study provides the first evidence of a molecular link between AP-1/GGA2 and EGFR in Rab11-positive recycling endosomes in both steady-state and EGF-stimulated conditions.
“Therefore, the present study provides the first evidence that shows a molecular link between AP-1/GGA2 and EGFR in Rab11-positive recycling endosomes in both the steady-state and EGF-stimulated conditions.”
Quote in the paperSubstantial claim - Interpretationown data
Rab11 itself is unlikely to be directly involved in AP-1/GGA2-mediated EGFR recycling.
“It is unlikely that Rab11 itself is directly involved in the AP-1/GGA2-mediated EGFR recycling, because Rab11 knockdown did not cause significant reduction of EGFR (Supplementary Fig. S3B), and Rab11 was not found in the list of EGFR interacting molecules in mass analysis (Supplementary Table S1).”
Quote in the paperNot a substantial claim - Premisecitation
GGA2 is able to interact with the juxta-membrane domain of EGFR, although this domain does not contain a typical ACLL motif.
“and that GGA2 is able to interact with the juxta-membrane domain of EGFR, although this domain does not contain a typical ACLL motif [15].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
- Premisecitation
H1975 cells harbor activating EGFR mutations.
“H1975 cells harbor activating EGFR mutations [17]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2005;2:e73. source
- Interpretationown data
The AP-1-EGFR interaction occurs independently of EGF signaling.
“Interestingly, the PLA signal did not significantly alter after EGF treatment (Supplementary Fig. S4C), suggesting the interaction occurs independently of the EGF signaling.”
Quote in the paperNot a substantial claim - Study design and conductown data
The proximity ligation assay specifically detects AP-1-EGFR interaction.
“These results indicate that the PLA specifically detects AP-1–EGFR interaction.”
Quote in the paperSubstantial claim - Study design and conductown data
The specificity of the antibody against γ1-adaptin in recognizing endogenous protein in paraffin-embedded human tissues was confirmed using cell pellets of AP-1-depleted H1975 cells.
“The specificity of the antibody against γ1-adaptin in recognizing the endogenous protein in paraffin-embedded human tissues was confirmed by using cell pellets of AP-1-depleted H1975 cells (Supplementary Fig. S7D).”
Quote in the paperSubstantial claim - Interpretationcitation
AP-1 and GGA2 could act in the recycling pathway of EGFR that evades ubiquitination.
“On the other hand, AP-1 and GGA2 could act in the recycling pathway of EGFR that evades ubiquitination, because they have lower affinities to ubiquitin compared with GGA3 [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Puertollano R, Bonifacino JS. Interactions of GGA3 with the ubiquitin sorting machinery. Nat Cell Biol. 2004;6:244–51. source
- Interpretationown data
Both AP-1 and GGA2 regulate cellular contents and cell surface expression of a subset of receptor tyrosine kinases in a cell-dependent manner.
“Together, these assays clearly indicate that, although their preferences are different, both AP-1 and GGA2 regulate cellular contents and cell surface expression of a subset of RTKs in a cell-dependent manner.”
Quote in the paperSubstantial claim - Interpretationown data
The cellular distribution of either AP-1 or GGA2 depends on the other's expression.
“Together, these results indicate that the cellular distribution of either AP-1 or GGA2 depends on the other’s expression.”
Quote in the paperNot a substantial claim - Interpretationown data
AP-1 and GGA2 play an important role in the maintenance of cell surface EGFR by regulating the receptor recycling pathway.
“AP-1 and GGA2 play an important role in the maintenance of cell surface EGFR by regulating receptor recycling pathway.”
Quote in the paperSubstantial claim
- Probably not a substantial claim. 18
- It may state two separate claims as one. 11
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Findingnone givenAP-1 is expressed in endosomes at higher levels in some cancer tissues.
“Moreover, AP-1 was expressed in endosomes at higher levels in some cancer tissues.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataMean AP-1 signal intensity was significantly higher in tumor than in non-tumor cells in NSCLC, but not in HCC or CRC.
“When the mean signal intensity was quantified, it was significantly higher in tumor than in non-tumor cells in NSCLC, but not in HCC or CRC (Fig. 8D)”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataKnockdown of AP-1 or GGA2 increases lysosomal degradation of EGFR and decreases its recycling to the plasma membrane.
“Given that the lysosomal degradation of EGFR is increased and its recycling to the PM is decreased by the knockdown of AP-1 (present study) and GGA2 (present study and [15])”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
It may state two separate claims as one.
Findingown dataAP-1 punctate signals overlapped well with EEA1-positive endosomes, but not at all or only partially with the TGN marker TGN46 in HCC, NSCLC, and CRC.
“double immunofluorescence microscopy demonstrated that punctate signals for AP-1 overlapped well with EEA1-positive endosomes, but not at all or only partially with the TGN marker TGN46 in HCC, NSCLC, and CRC (Fig. 8E and Supplementary Fig. S7E).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationCell surface EGFR is constitutively internalized and recycled back to the plasma membrane without ligand stimulation, and this balance is precisely regulated for maintenance of the cell surface-dominant localization of the receptor.
“Cell surface EGFR is also constitutively internalized and recycled back to the PM without ligand stimulation; this balance must be precisely regulated for the maintenance of the cell surface-dominant localization of the receptor [3, 4].”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim.
PremisecitationLigand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes.
“Since AP-1 has been shown to localize to Rab11-positive recycling endosomes [28], and ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes [29, 30], we examined if three molecules, EGFR, AP-1, and Rab11, could show colocalization in the cytoplasm.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF. Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE. 2013;8:e64817. source
- cites [30] Chi S, Cao H, Wang Y, McNiven MA. Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. J Biol Chem. 2011;286:35196–208. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationEGFR plays key roles in normal cellular functions and in the development of several types of cancer.
“The EGFR plays key roles not only in normal cellular functions but also in the development of several types of cancer cells [1, 2], and therefore, it is the therapeutic targets of several anti-cancer drugs.”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim.
PremisecitationAP-1 localizes to Rab11-positive recycling endosomes.
“Since AP-1 has been shown to localize to Rab11-positive recycling endosomes [28], and ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes [29, 30], we examined if three molecules, EGFR, AP-1, and Rab11, could show colocalization in the cytoplasm.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Matsudaira T, Niki T, Taguchi T, Arai H. Transport of the cholera toxin B-subunit from recycling endosomes to the Golgi requires clathrin and AP-1. J Cell Sci. 2015;128:3131–42. source
Probably not a substantial claim.
PremisecitationGGA2 maintains the cell surface expression of EGFR necessary for robust cell growth.
“GGA2 reportedly maintains the cell surface expression of EGFR necessary for robust cell growth [15]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
It may state two separate claims as one.
Interpretationown dataAP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and consequently cancer cell growth.
“Collectively, these results suggest that AP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and, consequently, cancer cell growth.”
- Also stated in: § Introduction · plain
“Here, we present evidence that AP-1 together with GGA2 controls EGFR recycling from endosomes, maintaining its cell surface expression and cell growth.”
Quote in the paperSubstantial claim- Also stated in: § Introduction · plain
Probably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationreasoningPredicted growth effects in cancer tissues may not be mediated solely by the upregulation of EGFR.
“However, predicted growth effects in cancer tissues may not be mediated solely by the upregulation of EGFR.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Study design and conductown dataDepletion of γ1-adaptin and EGFR was confirmed by western blotting.
“Depletion of γ1-adaptin and EGFR was confirmed by western blotting using the indicated antibodies (Ab).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationreasoningPotential AP-1/GGA2 targeting as an anti-cancer strategy is not dependent on activation mutations but on the intracellular recycling of EGFR.
“Nevertheless, it should be emphasized that potential AP-1/GGA2 targeting as an anti-cancer strategy is not dependent on activation mutations but on the intracellular recycling of EGFR, and that AP-1/GGA2 targeting could arrest multiple cancer-related signaling pathways that originate from different RTKs.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataGGA3 mainly functions in ligand-stimulated endocytosis and/or ubiquitin-dependent degradation of EGFR.
“Probably, GGA3 mainly functions in ligand-stimulated endocytosis and/or ubiquitin-dependent degradation of EGFR, since it hardly associated with EGFR at steady-state in this study (Fig. 1A).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitationμ1A-adaptin (AP1M1) has cell growth-promoting functions in hepatitis B virus-transfected HepG2 cells.
“and of μ1A-adaptin (AP1M1) in hepatitis B virus-transfected HepG2 cells [39].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Kou Y, Yan X, Liu Q, Wei X, Zhang B, Li X, et al. HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells. Oncol Lett. 2019;18:456–64. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationGGA2 gene is a cooperative driver of EGFR-mediated lung adenocarcinoma.
“GGA2 gene has been identified as a cooperative driver of EGFR-mediated lung adenocarcinoma [16]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] O’Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg AL, Martinez VD, et al. Integrative genomic analyses identifies GGA2 as a cooperative driver of EGFR-mediated lung tumorigenesis. J Thorac Oncol. 2019;14:656–71. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAP-1 localizes to Rab11-positive recycling endosomes, promoting retrograde transport of cholera toxin B-subunit from endosomes to the Golgi complex.
“AP-1 has been shown to localize to Rab11-positive recycling endosomes, thereby promoting retrograde transport of the cholera toxin B-subunit from endosomes to the Golgi complex [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Matsudaira T, Niki T, Taguchi T, Arai H. Transport of the cholera toxin B-subunit from recycling endosomes to the Golgi requires clathrin and AP-1. J Cell Sci. 2015;128:3131–42. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisecitationμ1A-adaptin has been identified as a possible predictive marker of metastasis to the central nervous system in triple-negative breast cancer.
“Moreover, μ1A-adaptin has been recently identified by proteomics analysis as a possible predictive marker of metastasis to the central nervous system in triple-negative breast cancer [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Rojas LK, Trilla-Fuertes L, Gamez-Pozo A, Chiva C, Sepulveda J, Manso L, et al. Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer. Ecancermedicalscience. 2019;13:891. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationLigand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes, promoted by the short form of EPS15 and Odin.
“Previous studies have demonstrated that ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes, which is promoted by the short form of EPS15 [30] and a tyrosine-phosphorylated component, Odin [29, 30].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [30] Chi S, Cao H, Wang Y, McNiven MA. Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. J Biol Chem. 2011;286:35196–208. source
- cites [29] Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF. Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE. 2013;8:e64817. source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAP-1 has cell growth-promoting functions in Arabidopsis.
“Previous studies have reported cell growth-promoting functions of AP-1 in Arabidopsis [38]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Park M, Song K, Reichardt I, Kim H, Mayer U, Stierhof YD, et al. Arabidopsis mu-adaptin subunit AP1M of adaptor protein complex 1 mediates late secretory and vacuolar traffic and is required for growth. Proc Natl Acad Sci USA. 2013;110:10318–23. source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductreasoningStudies on human samples were approved by the Institutional Review Board in Fukushima Medical University (approval number 2943), and informed consent was properly obtained.
“Studies on human samples were approved by the Institutional Review Board in Fukushima Medical University (approval number: 2943). For each human sample, informed consent was properly obtained as stated by the supplying companies (http://www.outdobiotech.com/strictsops.html).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationGGA3 promotes lysosomal degradation of EGFR after EGF stimulation.
“It should be noted that GGA3 has been previously shown to promote the lysosomal degradation of EGFR [12] after stimulation of EGF.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Puertollano R, Bonifacino JS. Interactions of GGA3 with the ubiquitin sorting machinery. Nat Cell Biol. 2004;6:244–51. source
Probably not a substantial claim.
Study design and conductnone givenThe EGFR internalization and recycling assay was confirmed to be within a range where band intensity is linearly proportional to protein concentration.
“This experimental assay was confirmed to be carried out within a range, where the band intensity is linearly proportional to the protein concentration.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationMET is overexpressed in HCC.
“since MET is known to be overexpressed in this type of tumor [42]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Giordano S, Columbano A. Met as a therapeutic target in HCC: facts and hopes. J Hepatol. 2014;60:442–52. source
Probably not a substantial claim.
PremisecitationAP-1 μ1-adaptin can recognize the tyrosine-based motif Y974RAL and YXXΦ-independent interfaces in the cytoplasmic domains of EGFR.
“It has been reported that the μ1-adaptin subunit of AP-1 can recognize the tyrosine-based motif, Y974RAL, and YXXΦ-independent interfaces in the cytoplasmic domains of EGFR [34, 35]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Huang F, Nesterov A, Carter RE, Sorkin A. Trafficking of yellow-fluorescent-protein-tagged mu1 subunit of clathrin adaptor AP-1 complex in living cells. Traffic. 2001;2:345–57. source
- cites [35] Sorkina T, Bild A, Tebar F, Sorkin A. Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors. J Cell Sci. 1999;112:317–27. source
The paper relies on this without support.
The molecular mechanisms of steady-state recycling of EGFR are poorly understood.
“However, the molecular mechanisms of this steady-state recycling of EGFR are poorly understood.”
The paper relies on this without support.
No study has explored the function of APs in the context of EGFR stability.
“However, to our knowledge, no study has explored the function of APs in the context of EGFR stability.”
The paper relies on this without support.
Activated EGFRs are internalized and transported into endosomes, where they are ubiquitinated by CBL and translocated into internal vesicles by ESCRT complexes, and finally transported into lysosomes for degradation.
“The fate of EGFR after ligand-binding has been intensively studied; activated EGFRs are internalized and transported into endosomes, where the receptors are ubiquitinated by CBL and translocated into internal vesicles by the action of ESCRT complexes, and finally transported into lysosomes for degradation.”
The paper relies on this without support.
H1975 cell growth depends on EGFR.
“since the growth of NSCLC-derived H1975 cells used in this study is known to depend on the EGFR”
The paper relies on this without support.
The AP-1 complex can function when it is recruited onto membrane compartments.
“the AP-1 complex can function when it is recruited onto the membrane compartments”
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
Mannose 6-phosphate receptors: new twists in the tale
Ghosh, P., Dahms, N. M., & Kornfeld, S. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1050 · Cited by 1,083
EGF receptor trafficking: consequences for signaling and cancer
Tomas, A., Futter, C. E., & Eden, E. R. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.002 · Cited by 779
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A. D., & Goh, L. K. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 776
Al-Nedawi, K. N. I., Meehan, B., Kerbel, R. S., ALLISON, A. C., & Rak, J. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804543106 · Cited by 691
Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
Zhang, H., Deng, T., Liu, R., Bai, M., Zhou, L., Wang, X., Li, S., Wang, X., Yang, H., Li, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15016 · Cited by 568
The GGA proteins: adaptors on the move
Bonifacino, J. S. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1279 · Cited by 329
Cooperation of GGAs and AP-1 in Packaging MPRs at the Trans-Golgi Network
Doray, B., Ghosh, P., Griffith, J., Geuze, H. J., & Kornfeld, S. (2002) · Science · doi:10.1126/science.1075327 · Cited by 312
Adaptor proteins involved in polarized sorting
Bonifacino, J. S. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201310021 · Cited by 251
Common principles in clathrin-mediated sorting at the Golgi and the plasma membrane
Traub, L. M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.04.005 · Cited by 208
Interactions of GGA3 with the ubiquitin sorting machinery
Puertollano, R., & Bonifacino, J. S. (2004) · Nature Cell Biology · doi:10.1038/ncb1106 · Cited by 196
Tetherin is an exosomal tether
Edgar, J. R., Manna, P. T., Nishimura, S., Banting, G., & Robinson, M. S. (2016) · eLife · doi:10.7554/elife.17180 · Cited by 161
Gomez, T. S., Gorman, J. A., Artal-Martinez de Narvajas, A., Koenig, A. O., & Billadeau, D. D. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0101 · Cited by 161
Park, M., Song, K., Reichardt, I., Kim, H., Mayer, U., Stierhof, Y.-D., Hwang, I., & Jürgens, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300460110 · Cited by 134
Adaptor protein complexes and disease at a glance
Sanger, A., Hirst, J., Davies, A. K., & Robinson, M. S. (2019) · Journal of Cell Science · doi:10.1242/jcs.222992 · Cited by 133
EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
Pinilla‐Macua, I., Grassart, A., Duvvuri, U., Watkins, S. C., & Sorkin, A. D. (2017) · eLife · doi:10.7554/elife.31993 · Cited by 108
(2008) · Experimental Cell Research · doi:10.1016/s0014-4827(08)00404-7 · Cited by 96
Trafficking of Epidermal Growth Factor Receptor Ligands in Polarized Epithelial Cells
Singh, B., & Coffey, R. J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170406 · Cited by 94
Mammalian GGAs act together to sort mannose 6-phosphate receptors
Ghosh, P., Griffith, J., Geuze, H. J., & Kornfeld, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308038 · Cited by 90
A cell-based assay for CD63-containing extracellular vesicles
Cashikar, A. G., & Hanson, P. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220007 · Cited by 70
Sabet, O., Stockert, R., Xouri, G., Brüggemann, Y., Stanoev, A., & Bastiaens, P. I. H. (2015) · Nature Communications · doi:10.1038/ncomms9047 · Cited by 64
Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors
Sorkina, T., Bild, A., Tebar, F., & Sorkin, A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.317 · Cited by 57
Chi, S., Cao, H., Wang, Y., & McNiven, M. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247577 · Cited by 53
Contribution of the clathrin adaptor AP-1 subunit µ1 to acidic cluster protein sorting
Navarro Negredo, P., Edgar, J. R., Wrobel, A. G., Zaccai, N. R., Antrobus, R., Owen, D. J., & Robinson, M. S. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201602058 · Cited by 50
Tavares, L., da Silva, E. M. L., da Silva-Januário, M. E., Januário, Y. C., de Cavalho, J. V., Czernisz, É. S., Mardones, G. A., & daSilva, L. L. P. (2016) · Journal of Cell Science · doi:10.1242/jcs.192104 · Cited by 42
Ryan, S., Verghese, S. K., Cianciola, N. L., Cotton, C., & Carlin, C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-12-1059 · Cited by 33
Rost, M., Döring, T., & Prange, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802632200 · Cited by 27
GGA3 mediates TrkA endocytic recycling to promote sustained Akt phosphorylation and cell survival
Li, X., Lavigne, P., & Lavoie, C. L. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-02-0087 · Cited by 26
Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability
Tong, J., Sydorskyy, Y., St-Germain, J. R., Taylor, P., Tsao, M. S., & Moran, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064817 · Cited by 25
O’Farrell, H., Harbourne, B., Kurlawala, Z., Inoue, Y., Nagelberg, A. L., Martinez, V. D., Lu, D., Oh, M. H., Coe, B. P., Thu, K. L., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.004 · Cited by 23
Emerging roles of Golgi/endosome-localizing monomeric clathrin adaptors GGAs
Uemura, T., & Waguri, S. (2019) · Anatomical Science International · doi:10.1007/s12565-019-00505-2 · Cited by 21
Self-citationComparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice
Miyakawa, R., Satô, A., Matsuda, Y., Saito, A., Abe, F., Matsumura, H., Odaka, M., Suzuki, T., Dohmae, N., Komatsuda, A., et al. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01898-5 · Cited by 14
Self-citationZizioli, D., Geumann, C., Kratzke, M., Mishra, R., Borsani, G., Finazzi, D., Candiello, E., & Schu, P. V. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.03.008 · Cited by 13
Rojas, K. L., Trilla-Fuertes, L., Gámez-Pozo, A., Chiva, C., Sepúlveda, J., Manso, L., Prado-Vázquez, G., Zapater-Moros, A., López-Vacas, R., Ferrer-Gómez, M., et al. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.891 · Cited by 13
(2015) · doi:10.1242/jcs.172171
Baguet, A. (2012) · PLoS One · doi:10.1194/jlr.m200276-jlr200
- Self-citation
- Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
New directions for the clathrin adaptor AP-1 in cell biology and human disease
Duncan, M. C. (2022) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2022.102079 · Cited by 50
Takahashi, J., Nakamura, S., Onuma, I., Zhou, Y., Yokoyama, S., & Sakurai, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-15838-8 · Cited by 14
Wang, J., Lau, P. K., Li, C. W., & Guo, Y. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102979 · Cited by 14
Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non‐small cell lung cancer
Jeong, J., Hwang, Y. E., Lee, M., Keum, S., Song, S., Kim, J., Choi, J., & Rhee, S. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31112 · Cited by 14
Shaldam, M. A., Khalil, A. F., Almahli, H., Jaballah, M. Y., Angeli, A., Khaleel, E. F., Badi, R. M., Elkaeed, E. B., Supuran, C. T., Eldehna, W. M., et al. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300449 · Cited by 12
Wang, J., & Zhu, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22382 · Cited by 7
Xu, Z., Li, Z. Z., Deng, Z., Ding, C., Wu, J., Zhang, C., Wei, H., He, T., Long, L., Tang, L., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01902-2 · Cited by 5
Liu, Y., Li, F., Wu, B., Huang, L., & Qi, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114385 · Cited by 4
RME-1-associated recycling endosomes participate in vitellogenin secretion in Caenorhabditis elegans
Zhai, C., & Dong, M. (2025) · Life Metabolism · doi:10.1093/lifemeta/loaf026 · Cited by 4
Hoshi, N., Uemura, T., Tachibana, K., Abe, S., Murakami-Nishimagi, Y., Okano, M., Noda, M., Saito, K., Kono, K., Ohtake, T., et al. (2024) · Breast Cancer · doi:10.1007/s12282-023-01539-1 · Cited by 4
Self-citationHuang, H., Hung, P.-F., Chen, Y.-P., & Lee, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031374 · Cited by 3
Jiang, R., Collins, K. A., Huffman, K. M., Hauser, E. R., Hubal, M. J., Johnson, J. L., Williams, R. B., Siegler, I. C., & Kraus, W. E. (2024) · Annals of Behavioral Medicine · doi:10.1093/abm/kaae011 · Cited by 1
Fitzpatrick, C. (2024) · eScholarship@McGill (McGill) · doi:10.82308/26882
ARF-1 coordinates cargo sorting at FERARI endosomal recycling hubs
Solinger, J. A., Franziscus, C. A., Nuredini, T., Müller, D., Clement, S., Ritz, D., Adarska, P., Bottanelli, F., & Spang, A. (2026) · The Journal of Cell Biology · doi:10.1083/jcb.202512157
Han, Y., Huang, Z., Zou, Y., Zhang, Y., Xin, H., Sun, M., Liu, Y., Zhang, M., & Li, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062905
Duclos, M. (2023) · theses.fr (ABES) · doi:10.70675/cddf5dbaz5c2bz4a63z98f1zb600c3ecd191
Tsukida, S., Uemura, T., Sato, N., Kofunato, Y., Ishigame, T., Kimura, T., Kenjo, A., Marubashi, S., & Waguri, S. (2026) · Research Square · doi:10.21203/rs.3.rs-9301878/v1
Self-citationGGAs : Regulation of Multiple Sorting Pathways and Potential Association With Human Diseases
Wang, Q., Mei, J., Li, S., Zhang, G., Qiu, J., & Li, X. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71215
Sánchez‐León, E., Bhalla, K., French, V., Beskrovnaya, P., Parmar, S., Hu, G., Lagace, M. A., Thanasack, S., Foster, E. J., Tocheva, E. I., et al. (2026) · Infection and Immunity · doi:10.1128/iai.00098-26
Metadata
- Authors
- Uemura, T., Suzuki, T., Dohmae, N., & Waguri, S.
- Affiliations
- Fukushima Medical University (JP)
- RIKEN Center for Sustainable Resource Science (JP)
- Corresponding author
- Waguri, Satoshi
- Venue
- Oncogenesis
- Published
- 2021-11-19
- Volume
- 10
- Issue
- 11
- Pages
- 80-80
- ISSN
- 2157-9024 (ISSN-L)
- PMC
- PMC8604998
- OpenAlex
- W3211778058
- Cited by
- 19
- References
- 45
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 2
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Oncogenesis (publishedVersion, cc-by)
- SSRN Electronic Journal (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- MEXT | Japan Society for the Promotion of Science (24659088, 15H04670, 26830080)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- epidermal growth factor receptor, AP-1, GGA2, recycling endosomes, early endosomes, receptor recycling, lysosomal degradation, MET, ErbB4, tyrosine kinase, cancer cell growth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review